Drug Recall Lawyer Blog

Here are the stories we’re following this week:

• Yasmin: Bayer is updating its European warning label after recent Swiss studies (HT: Tom Lamb)
• Direct-To-Consumer Drug Advertising: FDA proposes new regulations (HT: Mass Tort Defense Blog)
• Zicam: Update on the Zicam (nasal spray that may cause loss of sense of smell) MDL, pending in Phoenix (HT: Searcy Blog)
• Pain Pumps: California state judge cuts up pain pump claims (HT: Drug & Device Law Blog)
• Drug Companies: Three drug companies (Pfizer, Solvay, and Procter & Gamble) found to have breached the British Pharmaceutical Industry’s code of practice (HT: PharmaGossip)

Happy Monday!

As Ron Miller posted yesterday, the Judicial Panel on MultiDistrict Litigation approved an MDL for Zicam on October 9, 2009. Here’s a link to the Order.

The moving plaintiffs requested that the JPML send ten consumer class action cases to a federal district court, along with 30 later discovered related actions (“tag-along actions”). The Defendants, Matrixx Initiatives, Inc., Zicam, LLC and Zicam Swab, LLC, supported centralization, while other plaintiffs opposed it.

Continue reading "Zicam MDL Approved" »